Cellectar Biosciences, Inc. (CLRB)
3.04
+0.22
(+7.80%)
USD |
NASDAQ |
Feb 06, 16:00
3.06
+0.02
(+0.66%)
After-Hours: 20:00
Cellectar Biosciences EPS Diluted (Quarterly) : -1.405 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Imunon, Inc. | -1.165 |
| PDS Biotechnology Corp. | -0.1922 |
| PAVmed, Inc. | -8.807 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.444M |
| Total Expenses (Quarterly) | 4.444M |
| Enterprise Value | -4.711M |
| Earnings Yield | -212.8% |
| Normalized Earnings Yield | -375.01 |